The breakthrough of their drug NICOSAN in the management of sickle cell disease is going to be mass produced by the second quarter of the year. With this announcement it could bring a major profit.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.